nach oben

Erschienen in:

01.12.2019 | Editorial

Imminent fracture risk assessments in the UK FLS setting: implications and challenges

verfasst von: Rafael Pinedo-Villanueva, Mata Charokopou, Emese Toth, Kerry Donnelly, Cyrus Cooper, Daniel Prieto-Alhambra, Cesar Libanati, Muhammad K. Javaid

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Kanis J, McCloskey E, Harvey NC, Javaid MK, Borgstrom F (2018) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in the United Kingdom. Broken Bone, Broken Lives:. International Osteoporosis Foundation, http://share.iofbonehealth.org/EU-6-Material/Reports/IOF_report_UK.pdf, pp 1–19

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739CrossRef

Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065CrossRef

Klop C, Gibson-Smith D, Elders PJ, Welsing PM, Leufkens HG, Harvey NC, Bijlsma JW, van Staa TP, de Vries F (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int 26:1919–1928CrossRef

Boulton C, Gallagher C, Rai S, Tsang C, Vasilakis N, Javaid MK (2017) Royal College of Physicians. Fracture Liaison Service Database (FLS-DB) clinical audit. FLS forward: identifying high-quality care in the NHS for secondary fracture prevention. In Programme FaFFA (ed). Royal College of Physicians, London, pp 1–70

Javaid MK, Boulton C, Gallagher C, Judge A, Vasilakis N (2017) Fracture Liaison Service Database (FLS-DB) annual report: leading FLS improvement: secondary fracture prevention in the NHS. In Programme FaFFA (ed). Healthcare Quality Improvement Partnership, London

Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152CrossRef

Javaid MK, Kyer C, Mitchell PJ, et al. (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture(R) Best Practice Framework tool. Osteoporosis Int 26:2573–2578

Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046CrossRef

10.

Lems WF, Dreinhofer KE, Bischoff-Ferrari H et al (2017) EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis 76:802–810CrossRef

11.

Geusens P, Eisman JA, Singer A, Van Den Berg J (2019) Fracture Liaison Service. In Bilezikian JP (ed) Primer in the metabolic bone diseases and disorders of mineral metabolism. John Wiley & Sons INc, pp 405–411

12.

Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis Int 19:385–397CrossRef

13.

Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRef

14.

Collins GS, Mallett S, Altman DG (2011) Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ 342:d3651–d3651CrossRef

15.

Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444CrossRef

16.

National Clinical Guideline Centre N (2012) Osteoporosis: assessing the risk of fragility fracture: NICE clinical guideline 146. In (NICE) NIfHaCE (ed)

17.

National Clinical Guideline Centre N (2017) Osteoporosis: quality standard 149. In Excellence NIfHaC (ed)

18.

Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28:775–780CrossRef

19.

van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102CrossRef

20.

Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28:1765–1769CrossRef

21.

Kanis JA, Johansson H, Oden A et al (2018) Characteristics of recurrent fractures. Osteoporosis Int 29:1747–1757CrossRef

22.

Roux S, Cabana F, Carrier N, Beaulieu M, April PM, Beaulieu MC, Boire G (2014) The World Health Organization Fracture Risk Assessment Tool (FRAX) underestimates incident and recurrent fractures in consecutive patients with fragility fractures. J Clin Endocrinol Metab 99:2400–2408CrossRef

23.

Bynum JPW, Bell JE, Cantu RV, Wang Q, McDonough CM, Carmichael D, Tosteson TD, Tosteson ANA (2016) Second fractures among older adults in the year following hip, shoulder, or wrist fracture. Osteoporos Int 27:2207–2215CrossRef

24.

Bonafede M, Shi N, Barron R, Li X, Crittenden DB, Chandler D (2016) Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 11:26CrossRef

25.

Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387–394CrossRef

26.

van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P (2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporosis Int 17:348–354CrossRef

27.

Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR (2003) Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures. Osteoporos Int 14:130–136CrossRef

28.

Weycker D, Edelsberg J, Barron R, Atwood M, Oster G, Crittenden DB, Grauer A (2017) Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures. Osteoporos Int 28:2565–2571CrossRef

29.

NICE (2008) Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. NICE, London

30.

Inderjeeth CA, Chan K, Kwan K, Lai M (2012) Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments. J Bone Miner Metab 30:493–503CrossRef

31.

Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (London, England) 348:1535–1541CrossRef

32.

Harris ST, Watts NB, Genant HK, McKeever C, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344–1352

33.

Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391:230–240CrossRef

34.

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417–1427CrossRef

35.

Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, Watanabe K, Osakabe T, Shiraki M, Fukunaga M (2014) Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab 99:2599–2607CrossRef

36.

Jonsson E, Borgström F, Strom O, Toth E, LibanatI C, Stollenwerk B, Kanis JA, Charokopou M (2018) An Economic Value Framework to assess the cost-effectiveness of fracture prevention treatments in patients with osteoporosis at imminent risk of fracture. Value Health 21:S295–S295CrossRef

37.

Jonsson E, Ström O, Spångéus A, Åkesson K, Ljunggren Ö, Borgström F, Banefelt J, Toth E, Libanati C, Charokopou M (2017) Risk of major osteoporotic fracture (hip, vertebral, radius, humerus [MOF]) after first, second and third fragility fracture in a Swedish general population cohort. Value Health 20:A528CrossRef

38.

Griffin XL, Parsons N, Achten J, Fernandez M, Costa ML (2015) Recovery of health-related quality of life in a United Kingdom hip fracture population. The Warwick Hip Trauma Evaluation--a prospective cohort study. Bone Joint J 97-b:372–382CrossRef

39.

Lewiecki EM, Cummings SR, Cosman F (2013) Treat-to-target for osteoporosis: is now the time? J Clin Endocrinol Metab 98:946–953CrossRef

40.

Cummings SR, Cosman F, Lewiecki EM, Schousboe JT, Bauer DC, Black DM, Brown TD, Cheung AM, Cody K, Cooper C, Diez-Perez A, Eastell R, Hadji P, Hosoi T, Jan de Beur S, Kagan R, Kiel DP, Reid IR, Solomon DH, Randall S (2017) Goal-directed treatment for osteoporosis: a progress report from the ASBMR-NOF Working Group on goal-directed treatment for osteoporosis. J Bone Miner Res 32:3–10CrossRef

41.

Ferrari S, Reginster JY, Brandi ML, Kanis JA, Devogelaer JP, Kaufman JM, Feron JM, Kurth A, Rizzoli R (2016) Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos 11:37CrossRef

42.

Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44CrossRef

43.

Blain H, Masud T, Dargent-Molina P et al (2016) A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement. Aging Clin Exp Res 28:797–803CrossRef

44.

Senay A, Delisle J, Giroux M, Laflamme GY, Leduc S, Malo M, Nguyen H, Ranger P, Fernandes JC (2016) The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service. Osteoporos Int 27:3439–3447CrossRef

45.

Geusens P, Marin F, Kendler DL, Russo LA, Zerbini CAF, Minisola S, Body JJ, Lespessailles E, Greenspan SL, Bagur A, Stepan JJ, Lakatos P, Casado E, Moericke R, López-Romero P, Fahrleitner-Pammer A (2018) Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial. J Bone Miner Res 33:783–794CrossRef

Titel: Imminent fracture risk assessments in the UK FLS setting: implications and challenges
verfasst von: Rafael Pinedo-Villanueva
Mata Charokopou
Emese Toth
Kerry Donnelly
Cyrus Cooper
Daniel Prieto-Alhambra
Cesar Libanati
Muhammad K. Javaid
Publikationsdatum: 01.12.2019
Verlag: Springer London
Erschienen in: Archives of Osteoporosis / Ausgabe 1/2019
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-019-0569-2

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Gonarthrose | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Imminent fracture risk assessments in the UK FLS setting: implications and challenges

Excerpt

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Arthroskopie kann Knieprothese nicht hinauszögern

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update Orthopädie und Unfallchirurgie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Exploring the association between number, severity, location of fracture, and occiput-to-wall distance

Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia

Celiac disease and severe vitamin D deficiency: the case for anti-tissue transglutaminase antibody screening

Higher serum alkaline phosphatase activity in infants born to vitamin D–deficient mothers

Mortality and physical dependence following fragility hip fracture: data from a regional hip fracture registry in Sri Lanka

Influence of hospital adverse events and previous diagnoses on hospital care cost of patients with hip fracture

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Arthroskopie kann Knieprothese nicht hinauszögern

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update Orthopädie und Unfallchirurgie